Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Once-Daily Plazomicin for Complicated Urinary Tract Infections.

Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP; EPIC Study Group.

N Engl J Med. 2019 Feb 21;380(8):729-740. doi: 10.1056/NEJMoa1801467.

PMID:
30786187
2.

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.

Saad F, Fizazi K, Jinga V, Efstathiou E, Fong PC, Hart LL, Jones R, McDermott R, Wirth M, Suzuki K, MacLean DB, Wang L, Akaza H, Nelson J, Scher HI, Dreicer R, Webb IJ, de Wit R; ELM-PC 4 investigators.

Lancet Oncol. 2015 Mar;16(3):338-48. doi: 10.1016/S1470-2045(15)70027-6. Epub 2015 Feb 18.

PMID:
25701170
3.

Donor risk score and baseline biopsy CADI value predict kidney graft outcome.

Kahu J, Kyllönen L, Räisänen-Sokolowski A, Salmela K.

Clin Transplant. 2011 May-Jun;25(3):E276-83. doi: 10.1111/j.1399-0012.2011.01401.x. Epub 2011 Feb 9.

PMID:
21303414
4.

Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival.

Kahu J, Lõhmus A, Ilmoja M, Kirsimägi U, Timberg G, Peetsalu A.

Medicina (Kaunas). 2007;43(12):953-8.

5.

Impact of mycophenolate mofetil intolerance on early results of kidney transplantation.

Kahu J, Kyllönen L, Salmela K.

Transplant Proc. 2005 Oct;37(8):3276-9.

PMID:
16298571
6.

Kidney transplantation from 1119 deceased donors in Finland, 1991 to 2003: impact of donor factors.

Kyllönen L, Kahu J, Kyllönen L, Salmela K.

Transplant Proc. 2005 Oct;37(8):3248-52.

PMID:
16298561

Supplemental Content

Loading ...
Support Center